agmatine has been researched along with Idiopathic Parkinson Disease in 3 studies
Agmatine: Decarboxylated arginine, isolated from several plant and animal sources, e.g., pollen, ergot, herring sperm, octopus muscle.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this report, we utilize FTIR spectroscopy to characterize the changes in rotenone-induced damage in neuronal-like differentiated SH-SY5Y neuroblastoma cells in the presence or absence of agmatine." | 7.78 | Protective effects of agmatine in rotenone-induced damage of human SH-SY5Y neuroblastoma cells: fourier transform infrared spectroscopy analysis in a model of Parkinson's disease. ( Caccamo, D; Calabrò, E; Condello, S; Currò, M; Ferlazzo, N; Ientile, R; Magazù, S; Satriano, J, 2012) |
| " In this report, we utilize FTIR spectroscopy to characterize the changes in rotenone-induced damage in neuronal-like differentiated SH-SY5Y neuroblastoma cells in the presence or absence of agmatine." | 3.78 | Protective effects of agmatine in rotenone-induced damage of human SH-SY5Y neuroblastoma cells: fourier transform infrared spectroscopy analysis in a model of Parkinson's disease. ( Caccamo, D; Calabrò, E; Condello, S; Currò, M; Ferlazzo, N; Ientile, R; Magazù, S; Satriano, J, 2012) |
| " Such movements are considered restrictive problem associated with the chronic use of L-dopa in Parkinson's disease (PD) treatment; the thing that renders the definite pathological mechanism unclear." | 1.72 | Agmatine-mediated inhibition of NMDA receptor expression and amelioration of dyskinesia via activation of Nrf2 and suppression of HMGB1/RAGE/TLR4/MYD88/NF-κB signaling cascade in rotenone lesioned rats. ( Azar, YO; Badawi, GA; Ibrahim, SM; Zaki, HF, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Azar, YO | 1 |
| Badawi, GA | 1 |
| Zaki, HF | 1 |
| Ibrahim, SM | 1 |
| Bilge, SS | 1 |
| Günaydin, C | 1 |
| Önger, ME | 1 |
| Bozkurt, A | 1 |
| Avci, B | 1 |
| Condello, S | 1 |
| Calabrò, E | 1 |
| Caccamo, D | 1 |
| Currò, M | 1 |
| Ferlazzo, N | 1 |
| Satriano, J | 1 |
| Magazù, S | 1 |
| Ientile, R | 1 |
3 other studies available for agmatine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Agmatine-mediated inhibition of NMDA receptor expression and amelioration of dyskinesia via activation of Nrf2 and suppression of HMGB1/RAGE/TLR4/MYD88/NF-κB signaling cascade in rotenone lesioned rats.
Topics: Agmatine; Animals; Antioxidants; Dyskinesias; HMGB1 Protein; Levodopa; Myeloid Differentiation Facto | 2022 |
Neuroprotective action of agmatine in rotenone-induced model of Parkinson's disease: Role of BDNF/cREB and ERK pathway.
Topics: Agmatine; Animals; Apoptosis; Brain; Brain-Derived Neurotrophic Factor; Cell Survival; Corpus Striat | 2020 |
Protective effects of agmatine in rotenone-induced damage of human SH-SY5Y neuroblastoma cells: fourier transform infrared spectroscopy analysis in a model of Parkinson's disease.
Topics: Agmatine; Cell Line, Tumor; Humans; Models, Biological; Neuroblastoma; Parkinson Disease; Rotenone; | 2012 |